These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1315781)

  • 21. Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors.
    Zergeroğlu S; Aksakal O; Demirtürk F; Gökmen O
    Gynecol Obstet Invest; 2001; 51(1):60-3. PubMed ID: 11150878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cytokeratin profiles of ovarian common "epithelial" tumors.
    Duggan MA; Robertson DI
    Eur J Gynaecol Oncol; 1989; 10(2):73-9. PubMed ID: 2470591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Histological picture of the endometrium in epithelial ovarian neoplasms].
    Malarewicz A
    Ginekol Pol; 1979 Apr; 50(4):332-8. PubMed ID: 468049
    [No Abstract]   [Full Text] [Related]  

  • 24. Surface (germinal) epithelium and related ovarian neoplasms.
    Blaustein A
    Pathol Annu; 1981; 16 Pt 1():247-94. PubMed ID: 7329732
    [No Abstract]   [Full Text] [Related]  

  • 25. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
    Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
    Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types.
    Kao GF; Norris HJ
    Obstet Gynecol; 1979 Dec; 54(6):729-36. PubMed ID: 514560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian epithelial tumours of borderline malignancy: pathological features and current status.
    Br J Obstet Gynaecol; 1983 Aug; 90(8):743-50. PubMed ID: 6309211
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
    Henzen-Logmans SC; Berns EM; Klijn JG; van der Burg ME; Foekens JA
    Br J Cancer; 1992 Dec; 66(6):1015-21. PubMed ID: 1457340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of EGF-R in malignant surface epithelial ovarian neoplasms (SEON).
    Janinis J; Nakopoulou L; Panagos G; Davaris P
    Eur J Gynaecol Oncol; 1994; 15(1):19-23. PubMed ID: 8206065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic significance of morphological parameters in malignant epithelial ovarian tumors].
    Breitenecker G; Bartl W; Scheiber V
    Pathologe; 1983 Jan; 4(1):29-40. PubMed ID: 6302656
    [No Abstract]   [Full Text] [Related]  

  • 31. E-cadherin expression in human epithelial ovarian cancer and normal ovary.
    Sundfeldt K; Piontkewitz Y; Ivarsson K; Nilsson O; Hellberg P; Brännström M; Janson PO; Enerback S; Hedin L
    Int J Cancer; 1997 Jun; 74(3):275-80. PubMed ID: 9221804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value.
    Meden H; Marx D; Raab T; Kron M; Schauer A; Kuhn W
    J Obstet Gynaecol (Tokyo 1995); 1995 Apr; 21(2):167-78. PubMed ID: 8556578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ras oncogene product p21 expression and prognosis of human ovarian tumors.
    Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
    Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
    Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
    Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
    Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
    McCluggage WG; Young RH
    Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian mucinous cystadenocarcinoma with mural nodule of carcinomatous derivation. A light and electron microscopic study.
    Czernobilsky B; Dgani R; Roth LM
    Cancer; 1983 Jan; 51(1):141-8. PubMed ID: 6821801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series.
    Ben-Mussa A; McCluggage WG
    Histopathology; 2021 Feb; 78(3):445-452. PubMed ID: 32810322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histopathologic status as a prognostic factor in ovarian cancer].
    Schieder K; Breitenecker G; Köbl H; Bieglmayer C
    Gynakol Rundsch; 1990; 30 Suppl 1():147-50. PubMed ID: 1964147
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunocytochemical staining of ovarian tumours with Ov632.
    Owens OJ; Mutch F
    Cytopathology; 1992; 3(3):161-6. PubMed ID: 1511121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.